Virginia Biotechnology Association

Together, We're Working Wonders in Virginia

Sabin’s Hotez Awarded RSHTM Honorary Fellowship

Prof. Peter Hotez, MD, PhD was named today an Honorary Fellow of the Royal Society of Hygiene and Tropical Medicine (RSHTM). The award has been a tradition of RSHTM for more than 100 years and is presented to individuals who have made outstanding contributions towards the objectives of the Society.  RSHTM’s mission is to promote and advance the study, control, prevention and treatment of tropical diseases, to facilitate discussion, exchange of information and promotion of the health of those affected by tropical diseases.

Dr. Hotez is President of the Sabin Vaccine Institute in Washington D.C., whose mission is to reduce the suffering from infectious and neglected tropical diseases. Founded in 1993, Sabin builds bridges between leaders in science, academia, industry, and government to conduct research and create science-based solutions to worldwide health threats. As President of Sabin, Hotez was a co-founder, along with RSHTM President and Profs. David H. Molyneux and Alan Fenwick, Managing Director Kari Stoever and several others, of the Global Network for Neglected Tropical Diseases. The Global Network was launched at the Clinton Global Initiative in 2006 with the goal of eliminating the suffering of the 1.4 billion people worldwide suffering from neglected tropical diseases. Dr. Hotez is also a Distinguished Research Professor and Walter G. Ross Professor and Chair of the Department of Microbiology, Immunology, and Tropical Medicine at George Washington University and Principal Scientist and Founding Director of the Human Hookworm Vaccine Initiative (HHVI), which created the first-ever vaccine development program against human hookworm infection.

As President of Sabin, he also works with the Sabin team on developing vaccines for the neglected tropical disease schistosomiasis and on vaccine advocacy and sustainable immunization financing to ensure that even the very poorest people have access to essential vaccines and that their governments build capacity to procure vaccines and deliver these life-saving products.